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Analysis of mycobacterial strains that have lost their ability to cause disease is a powerful approach to identify yet
unknown virulence determinants and pathways involved in tuberculosis pathogenesis. Two of the most widely used
attenuated strains in the history of tuberculosis research are Mycobacterium bovis BCG (BCG) and Mycobacterium
tuberculosis H37Ra (H37Ra), which both lost their virulence during in vitro serial passage. Whereas the attenuation of
BCG is due mainly to loss of the ESAT-6 secretion system, ESX-1, the reason why H37Ra is attenuated remained
unknown. However, here we show that a point mutation (S219L) in the predicted DNA binding region of the regulator
PhoP is involved in the attenuation of H37Ra via a mechanism that impacts on the secretion of the major T cell antigen
ESAT-6. Only H37Ra ‘‘knock-ins’’ that carried an integrated cosmid with the wild-type phoP gene from M. tuberculosis
H37Rv showed changes in colony morphology, increased virulence, ESAT-6 secretion, and induction of specific T cell
responses, whereas other H37Ra constructs did not. This finding established a link between the PhoP regulator and
ESAT-6 secretion that opens exciting new perspectives for elucidating virulence regulation in M. tuberculosis.
Citation: Frigui W, Bottai D, Majlessi L, Monot M, Josselin E, et al. (2008) Control of M. tuberculosis ESAT-6 secretion and specific T cell recognition by PhoP. PLoS Pathog 4(2):
e33. doi:10.1371/journal.ppat.0040033
Introduction
125 years of intense research on the major human pathogen
Mycobacterium tuberculosis have passed since its discovery by
Robert Koch, resulting in a huge body of knowledge. In spite
of the great progress that has been made in the understanding
of some basic features of its pathogenesis, tuberculosis
remains a major threat to human life in most parts of the
world. Indeed, M. tuberculosis has retained many secrets of its
so successful pathogenic lifecycle. Among the different
possibilities to obtain new insight into the mechanisms
employed by M. tuberculosis to infect its host, the analysis of
attenuated strains is one promising approach, and there are
some well-documented examples of laboratory-attenuated
strains. One of them is the ‘‘Bacille de Calmette et Gue´rin’’
(BCG), which was originally derived in 1921 from a virulent
Mycobacterium bovis strain by 230 passages on potato-glycerol-
ox bile medium [1]. The genetic lesions of BCG have recently
been determined [2–4], revealing that the loss of region of
difference 1 (RD1), which encodes part of the ESX-1 secretion
system [5], was one of the key events in its attenuation.
Another famous example of an attenuated strain is M.
tuberculosis H37Ra (‘‘a’’ for avirulent) (H37Ra). This strain was
obtained in 1934 by serial passage of patient isolate M.
tuberculosis H37 through media with different pHs [6] and
since then has been widely used in many laboratories in the
world. Despite its long use, the reasons for its stable
attenuation have not yet been elucidated. As H37Ra is
derived from the same parent strain as M. tuberculosis H37Rv
(‘‘v’’ for virulent) (H37Rv), the sequenced paradigm strain of
tuberculosis research [7], genomic comparisons of the
attenuated and virulent variants of M. tuberculosis H37 are
particularly interesting and have the potential to identify
subtle genetic changes that might be responsible for the
phenotypic differences observed between the two strains. In a
previous study we have tried to reveal these determinants [8],
but the methods employed only identified large genetic
polymorphisms, associated with IS6110, which were not
found to be responsible for the attenuation of H37Ra [8].
In another study, Pascopella et al. [9] transformed a cosmid
library of H37Rv into H37Ra and then selected for clones that
were enriched on passage through the mouse. A number of
overlapping cosmid clones that gave enhanced growth and
survival in the spleens of infected mice relative to that of
wild-type H37Ra were identified [9]. However, the effects of
these complementation attempts on virulence remained
limited, and no sequence information was described, which
makes it difficult now to identify the genes implicated. H37Ra
was also the subject of extensive micro-array based analyses,
including whole genome comparative DNA/DNA analyses [10]
and transcriptional studies [11,12], which have identified
some candidate genes that were consistently downregulated.
However, a definitive conclusion about the molecular
determinants of the attenuation could not be drawn.
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As all these previous attempts have failed to identify the
genetic basis for the attenuation, we subjected H37Ra to
microarray-based DNA re-sequencing (NimbleGen Systems).
This technique has previously permitted single nucleotide
polymorphisms (SNPs) of a PA-824 drug resistant mutant
strain of H37Rv to be detected [13]. This approach was
combined with gene ‘‘knock-in’’ strategies, to complement
selected lesions, that allowed recombinant H37Ra strains to
be engineered, whose virulence and immunogenicity were
then evaluated in in vitro, ex vivo and animal models. This
strategy led us to identify and characterize a point mutation
in the phoP/phoR two-component regulatory system of H37Ra
that has uncovered novel regulatory links, which impact on
the secretion and T cell recognition of the major T cell
antigens ESAT-6 and CFP-10.
Results
Microarray-Based Comparative Genome Sequencing of M.
tuberculosis H37Ra
The genome-wide comparative mutational analysis of
H37Ra and H37Rv was carried out by NimbleGen Systems
following a previously published method [13]. Putative SNPs
with high probability scores were separated into synonymous
and non-synonymous SNPs of which the latter were verified
by conventional dye terminator cycle sequencing. By this
combined approach we identified 13 non-synonymous SNPs
that differed between the H37Ra and H37Rv strains used
(Table S1). We were particularly interested in a C to T
mutation responsible for the serine to leucine replacement at
position 219, S219L, of the two-component regulator PhoP as
this protein is well known for its involvement in the virulent
phenotype of M. tuberculosis [14]. Importantly, on inspection
of the structure of the PhoP-ortholog from Bacillus subtilis, it
was found that the equivalent residue Ser 207 is a main
residue in the DNA-binding domain, helix alpha3 [15]. For
the other 13 genes we found no indication that would identify
them as potential virulence genes, as none of them belong to
the 5% of genes that were previously determined by trans-
poson site hybridization (TraSH) as being essential for in vivo
growth of M. tuberculosis [16].
While writing this article, the whole genome sequence of
H37Ra became publicly available (NC_009525), and compar-
ison of the SNP data obtained from the H37Ra strain used in
our laboratory (Table S1) with the NC_009525 data, showed
that some differences existed between the H37Ra strains, a
phenomenon which was also previously observed for BCG [4]
and H37Rv [17]. Nevertheless, the S129L mutation in PhoP,
which we consider an important SNP involved in the
attenuation and reduced immunogenicity of H37Ra, is
identical in all H37Ra strains.
Rationale for Knock-Ins
To evaluate the phenotypic effect of the different SNPs and
to assess their potential contribution to the attenuation
process, we undertook functional genomic analyses using
knock-ins of H37Ra, as described previously [18]. Clones
spanning the different genomic regions of non-synonymous
SNPs were selected from an ordered H37Rv library of
integrating shuttle cosmids [7,19] and individually electro-
porated into H37Ra, where they inserted stably into the attB
site. By this approach we obtained appropriately comple-
mented transformants for the SNPs in genes fadE5, rpsL, and
phoP (Table S1), using cosmids I230, I563, and I36, respec-
tively. Based on the known role of phoP in virulence [14], the
H37Ra strain complemented with I36 (H37Ra::phoP) was
accorded highest priority for further molecular character-
ization and functional analyses, whereas the two other
recombinants (H37Ra::fadE5, H37Ra::rpsL) served as controls.
Figure S1 shows part of the nucleotide sequence of a PCR-
amplified fragment obtained from H37Ra::phoP. It is clearly
visible that at nucleotide position 656 of phoP two peaks exist,
one originating from the SNP present in H37Ra and one
from the integrated cosmid I36 carrying the H37Rv wild-type
copy of phoP. Similar results were also obtained for the SNPs
in fadE5 and rpsL using cosmids I230 and I563, respectively
(Figure S1). Correct integration of I36 was also confirmed by
Southern blot. As depicted in Figure S2, hybridization of SpeI-
digested genomic DNA with a 32P labeled phoP probe resulted
in two bands of different sizes, one corresponding to the SpeI
fragment harboring the H37Ra phoP gene (50 kb), and the
other to the larger SpeI fragment created by integration of the
I36 cosmid into the genome of H37Ra at the attB site. The
successful integration of the cosmid was also reflected by a
change in colony morphology that is shown in Figure S3.
Indeed, Steenken and colleagues originally selected the
H37Ra mutants mainly on the basis of the changes in colony
morphology [6].
Ex Vivo Virulence Studies
Changes in the regulatory potential of a pathogen are often
accompanied by altered virulence. In a first attempt to
determine the virulence of the complemented H37Ra knock-
in strains relative to wild-type H37Ra and H37Rv, bone
marrow–derived murine macrophages (BMM) were infected
with the different strains at a multiplicity of infection (MOI)
of 1:1 and 10:1 bacteria per cell. As depicted in Figure 1,
macrophages were able to control ex vivo growth of H37Ra,
but failed to control growth of H37Rv, confirming results
from Freeman and colleagues [20]. When H37Ra knock-ins
were tested, important differences in their ex vivo growth
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Author Summary
Mycobacterium tuberculosis, the causative agent of human tuber-
culosis is an extremely successful human pathogen in spite of its
lack of classical virulence factors, such as toxins. The pathogenesis of
this bacterium is closely linked with its ability to circumvent
destruction by the host cell, which depends on a large variety of
mycobacterial lipids and secreted proteins. Genome comparison of
fully virulent strains with closely related, but attenuated strains that
have lost their ability to cause disease is a powerful approach to
identify factors contributing to mycobacterial virulence. In this study
we have compared the virulent paradigm strain of tuberculosis
research M. tuberculosis H37Rv, with the widely used, attenuated
laboratory variant, H37Ra. This analysis, combined with gene
complementation studies, has identified a mutation in the two-
component system regulator PhoP that impacts on the secretion
and T cell recognition of the 6-kD early-secreted antigenic target
ESAT-6. In previous studies, both PhoP and the ESAT-6 secretion
system ESX-1 have been identified independently as major virulence
determinants of M. tuberculosis, so the finding that their action is
interconnected opens exciting new insights and perspectives into
the virulence regulation of tubercle bacilli.
characteristics were found. Whereas H37Ra::fadE5 (Figure 1)
and H37Ra::rpsL (unpublished data) showed very little or no
growth over the 7-d period, the H37Ra::phoP mutant grew
more vigorously, with a 7.5-fold increase in colony-forming
units (CFU) over the 7-d period. From these experiments we
concluded that complementation of H37Ra with the phoP
wild-type copy partially restored its virulence, but not to the
extent of the fully virulent H37Rv strain.
Virulence Studies of H37Ra Complemented Mutants in a
Mouse Model
Further assessment of the in vivo growth of different
H37Ra knock-in strains was carried out by intravenous
infection of severe combined immuno-deficient (SCID) mice.
Complementation of H37Ra with the PhoP-expressing
cosmid increased the virulence of the H37Ra::phoP recombi-
nant relative to H37Ra, resulting in a 1.0 log and 0.5 log
increase in CFU number in lungs and spleens, respectively. In
contrast, no effects on the virulence were observed when
H37Ra was complemented with fadE5 (Figure 2) or rpsL
(unpublished data). However, as already observed in macro-
phages, integration of phoP did not restore levels of virulence
to those of the reference strain H37Rv (Figure 2). This
situation is also reflected in the sizes of spleens, which
correlate with the CFU data in spleens (Figure S4).
Together with the data from the macrophage infection
assay, the results from the mouse infection show that the
S219L mutation in the phoP gene definitely represents one
genetic lesion that contributed to the attenuation of the
H37Ra strain.
Link between Mutation in phoP and Secretion of ESAT-6
As PhoP fulfills important regulatory functions in M.
tuberculosis [21,22], it was of primary interest to identify and
study potential effector molecules whose involvement in host
pathogen interaction were influenced by the point mutation
in phoP of H37Ra. Since secreted proteins of the ESX-1 system
of M. tuberculosis constitute a major interface between the
bacterium and its host [23], we analyzed the different strains
for their potential to induce T cell responses against ESAT-6
and its binding partner, the 10-kD culture filtrate protein
CFP-10. Groups of C57BL/6 mice were subcutaneously
inoculated with H37Rv, H37Ra, or one of three recombinant
H37Ra strains complemented with phoP, fadE5, or rpsL,
respectively. Two weeks after vaccination we assessed the
interferon-c (IFN-c) production of splenocytes mounted
against ESX-1 antigens or controls. As anticipated, all tested
strains induced IFN-c production in response to purified
protein derivative (PPD) but not to a control peptide (Mal-E),
indicating successful vaccination (Figure 3).
Most importantly, the various strains differed extensively in
their potential to induce antigen specific T cell responses
towards ESAT-6 and CFP-10. As shown in Figure 3,
splenocytes from mice that were inoculated with H37Rv
produced high amounts of IFN-c upon stimulation with
Figure 1. Macrophage Infection Studies
Bone marrow–derived murine macrophages (BMM) were infected with M. tuberculosis H37Ra, H37Ra::fadE5, H37Ra::phoP, and H37Rv at a MOI of ca. 1:1
and 10:1 bacteria per cell (A and B, respectively). The figure shows the means and standard deviations of CFU ratio values (CFU at days 1, 4, and 7
relative to CFU at 4 h) obtained in a representative experiment performed in quadruplicate. The significant difference levels in growth characteristics
between H37Ra and other strains (H37Ra::phoP and H37Rv) were determined by analysis of variance (ANOVA) (*p , 0.025, **p , 0.01, ***p , 0.005).
doi:10.1371/journal.ppat.0040033.g001
Figure 2. Virulence in the Murine Model
Number of colony-forming units (CFU) in the lungs and spleens of severe
combined immunodeficient (SCID) mice 1 d and 3 wk after intravenous
(i.v.) infection with ca. 106 CFU. The significance of differences between
CFU values obtained in mice infected with H37Ra and other strains
(H37Ra::phoP and H37Rv) was determined by ANOVA (*p, 0.025, ***p,
0.005).
doi:10.1371/journal.ppat.0040033.g002
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ESAT-6 or CFP-10, whereas the responses of H37Ra,
H37Ra::fadE5, and H37Ra::rpsL infected mice were extremely
weak. In contrast, splenocytes from H37Ra::phoP inoculated
mice showed very strong IFN-c production in response to
incubation with ESAT-6 and CFP-10.
Exactly the same trend was observed when a highly
sensitive T cell hybridoma assay was used to investigate
ESAT-6 secretion. This test is based on the presentation of
the immunodominant epitope contained in the first 20 amino
acids of ESAT-6 by H37Ra, recombinant H37Ra, or H37Rv
infected bone marrow–derived dendritic cells (BM-DC) to an
ESAT-6-specific T cell hybridoma (NB11), restricted by I-Ab.
Figure 4A shows that infection of BM-DC with H37Ra or
H37Ra::rpsL induced no stimulation of the hybridoma as
judged by IL-2 production, while H37Ra::phoP or H37Rv
triggered high amounts of IL-2 production in this very
sensitive and specific test. All strains behaved comparably
towards the Ag85A:241–260 control, emphasizing the specif-
icity of the observed phenomenon for ESAT-6 (Figure 4B).
To further evaluate the involvement of phoP and the ESX-1
system in immunogenicity, C57BL/6 mice were vaccinated
with additional strains. Firstly, we constructed a partially
diploid H37Ra knock-in strain carrying cosmid RD1-ppe68-ko
that, in BCG yields the greatest amounts of ESAT-6
expression and secretion [24]. However, in H37Ra the
presence of this cosmid could not increase the weak ESAT-
6 and CFP-10 T cell responses (Figure 3B) in the splenocyte
IFN-c assay. Secondly, we also tested the previously described
M. tuberculosis MT103 phoP knock-out (ko) strain SO2 [14,25]
in this assay and found that this strain induced a potent PPD
response as previously reported [25]. However, in comparison
to the corresponding MT103 wild-type strain, the SO2 strain
showed a strongly reduced ESAT-6 and CFP-10 specific T cell
response, corresponding to a similar low level as the H37Ra
strain (Figure 3B).
Altogether, our data obtained from multiple replicate
experiments indicate that a direct link exists between a fully
functional PhoP and the ability to generate T cell responses
against ESAT-6 and CFP-10.
Functional Characterization of Knock-In Mutants
We have previously shown that antigen-specific IFN-c
production of splenocytes is a reliable readout system to
evaluate whether or not ESAT-6 was secreted by recombinant
strains [23,24,26]. Thus, in order to determine the reason for
the observed failure of H37Ra to induce ESAT-6-specific
responses, H37Rv and H37Ra strains were tested for their
potential to express and secrete ESAT-6 in vitro. The western
blot analysis presented in Figure 5 shows that the cell lysates
of H37Ra and H37Ra::rpsL contain large amounts of ESAT-6,
indicating that the antigen is properly expressed. However,
Figure 3. T Cell Responses in Mice
ESAT-6- and CFP-10-specific T cell responses induced by various M. tuberculosis strains 2 wk after immunization. IFN-c production by splenocytes in
response to different antigens is expressed in ng/ml. (A) First panel of strains tested. (B) Second panel of strains tested for confirmation purposes.
doi:10.1371/journal.ppat.0040033.g003
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hardly any ESAT-6 was present in the culture filtrates of these
cultures, indicating that these strains were unable to secrete
ESAT-6 under the in vitro conditions employed in spite of
proper expression. Similar results were obtained for H37Ra::-
fadE5 (unpublished data). In contrast, from examination of
the western blots of M. tuberculosis H37Ra::phoP and H37Rv it
is clear that a large portion of their ESAT-6 protein is
secreted into the culture filtrates.
Analysis of the M. tuberculosis MT103 phoP ko strain SO2
showed strong expression of ESAT-6, but only very little
secreted ESAT-6 (Figure 5). In a previous report [25], the
presence of ESAT-6 in cell free extracts was described for this
strain, but no secretion assay was performed. Together, our
findings correlate perfectly with the in vivo data described
above and suggest that the lack of ESAT-6 specific T cell
recognition for H37Ra, H37Ra::fadE5, H37Ra::rpsL, and SO2 is
not caused by a loss of ESAT-6 expression, but rather due to a
failure of (phoP dependent) ESAT-6 secretion.
The observation that knocking-in the ESX-1 region of
H37Rv into H37Ra (H37Ra::RD1-ppe68-ko), and the resultant
diploidy, did not improve the ESAT-6-specific T cell
responses (Figure 3B), further argues that PhoP-dependent
ESAT-secretion might be regulated via a mechanism that lies
outside the RD1 region.
As closer inspection of the available literature on tran-
scriptional analyses of a H37Rv-phoP ko strain [21] and H37Ra
[12] suggested that the expression of gene cluster rv3612c-
rv3616c is reduced in both strains, we evaluated the
expression level of rv3614c in H37Rv, H37Ra, and H37Ra::-
phoP by quantitative real time PCR (qRT-PCR). In previous
studies rv3614c, rv3615c, rv3616c (espA) were independently
shown to be essential for proper ESAT-6 secretion [27,28]. We
confirmed the trend that rv3614c was expressed much lower
in H37Ra compared to H37Rv by qRT-PCR (Figure 6),
whereas expression of rv3614c in H37Ra::phoP was restored
to wild-type levels, suggesting that the rv3612c-rv3616c gene
cluster is regulated by PhoP. Interestingly, expression of phoP
was higher in H37Ra than in H37Rv (Figure 6). These findings
are consistent with data from a previous transcriptional study
[12] and suggest that the proposed ability of PhoP to
downregulate its own expression [22] is affected by the
S219L phoP mutation [29]. They also indicate that it is not a
lack of phoP expression that is causing the phoP-associated
effects in H37Ra.
Figure 4. Antigen-Specific IL-2 Production of T Cell Hybridomas
Analysis of IL-2 secretion by anti-ESAT-6 or anti-Ag85A T cell hybridomas in response to recognition of antigen presented by bone marrow–derived
dendritic cells (BM-DC) incubated with homologous or control peptides or infected with H37Rv, H37Ra or recombinant H37Ra strains.
doi:10.1371/journal.ppat.0040033.g004
Figure 5. Secretion Analysis
In vitro expression and secretion of ESAT-6 from M. tuberculosis H37Rv,
H37Ra, MT103 phoP ko (SO2), and recombinant H37Ra complemented
with integrating cosmids carrying genes phoP or rpsL from H37Rv. Total
protein concentrations were determined by using Bio-Rad protein assay,
and 15-lg samples were subjected to SDS-PAGE. Detection was carried
out by using monoclonal anti-ESAT-6 antibody Hyb 76–8a.
doi:10.1371/journal.ppat.0040033.g005
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Discussion
The attenuated H37Ra strain was obtained at the Trudeau
Institute in the 1930s in an attempt to dissociate virulent and
avirulent forms of the tubercle bacillus H37. Steenken et al.
have shown that the virulence of the H37 strain was
associated with colony morphology and that the avirulent
variant H37Ra failed to propagate in an ordinarily suscep-
tible host while the virulent variant H37Rv was able to
proliferate [6]. Although these different H37 daughter strains
have been available for many years now and belong to the
standard strain collections of almost every tuberculosis
diagnostic or research laboratory in the world [30,31], the
genetic basis of the decreased virulence of H37Ra remained
unknown.
The identification of the amino acid change S219L in the
predicted DNA binding region of the C-terminal effector
domain of PhoP [15,22] in H37Ra was therefore a particularly
exciting finding that has the potential to explain part of the
attenuation of the H37Ra strain and to elucidate the PhoP/
PhoR associated complex regulatory network in M. tuber-
culosis. In the bacterial world the PhoP/PhoR like two-
component systems are widely distributed and fulfill a large
variety of functions including sensing phosphate and magne-
sium [32,33], or regulating virulence genes [34]. For M.
tuberculosis, several studies have described a link between the
inactivation of phoP and loss of virulence, suggesting that the
phoP gene is required for intracellular growth ofM. tuberculosis
[14,25]. It was also found that the PhoP-PhoR system controls
the biosynthesis of polyketide-derived lipids [35] and deter-
mines the amount of triacylated and monoacylated lip-
oarabinomannans in M. tuberculosis [36]. However, according
to very recent information, these polyketide-derived (Pks2–4)
lipids do not have a strong impact on the virulence of M.
tuberculosis [29]. Finally, microarray-based trancriptome anal-
ysis using the wild-type versus a phoP ko mutant of H37Rv has
provided an overview of the transcriptional regulation linked
to PhoP [21]. That study identified 44 genes in the phoP-ko
strain that were expressed at least 2.5-fold lower in the
mutant than their counterparts in the M. tuberculosis wild-type
strain.
Most interestingly, about two thirds of these 44 genes were
also found substantially lower expressed in H37Ra in
comparison to H37Rv, when the transcriptional profiles of
H37Ra and H37Rv cultures grown in various media were
examined [12]. This finding argues that the PhoP S219L
mutation likely has a broad impact on gene regulation in
H37Ra with effects similar to those seen for complete
inactivation of phoP. Among the genes expressed at low level
in the phoP-ko strain and in H37Ra were several that are
involved in lipid metabolism; for example, the polyketide
synthases pks2 (rv3825c) or the Pks-associated protein papA1
(rv3824c). There were also several ppe genes that seem to be
regulated by phoP but not ppe68 [21]. In addition, NirA
(Rv2391), a putative nitrite reductase and MmpL10-FadD21
(Rv1183-85c), which were all identified by TraSH analysis as
potentially implicated in virulence [16], seem to be regulated
by PhoP [12,21].
However, the most striking link in relation to our results on
phoP and ESAT-6 secretion that was revealed by these two
transcriptional analyses, were the data on gene cluster
rv3612c-rv3616c. Closer inspection of the data published in
the corresponding supplemental materials showed that
rv3612c-rv3616c were strongly downregulated in the H37Rv
phoP ko mutant as well as in H37Ra [12,21]. These tran-
scriptome data corroborate our results obtained by quanti-
tative RT-PCR using probe rv3614c, which showed that gene
rv3614c was definitely expressed much lower in H37Ra than
in H37Rv and H37Ra::phoP strains (Figure 6). Since in
previous, independent studies it has been demonstrated that
functions of the rv3614c-rv3616c (espA) gene cluster were
essential for the secretion of ESAT-6 and CFP-10 [27,28], it is
quite probable that the lack of ESAT-6-specific T cell
responses observed for strains H37Ra and SO2 (Figure 3)
might be caused by the insufficient expression of rv3612c-
rv3616c, which results from the lack of a fully functional PhoP
in these strains. Moreover, the expression values of genes
rv3612c-rv3616c in H37Rv described in the article by Gao et
al. [12] show substantial differences between cultures grown
in roller bottles relative to cultures grown in shake flasks,
arguing that this gene cluster might be regulated by
environmental conditions through the PhoP/PhoR system. It
Figure 6. Quantitative RT-PCR
Expression levels of genes rv3614c, rv3865, rv3867, and phoP in duplicate cultures of M. tuberculosis H37Ra and H37Ra::phoP and H37Rv evaluated by
quantitative RT-PCR (qRT-PCR). Genes rv3865 and rv3867 were included as controls as these genes are encoded in the region of difference 1 (RD1) and
show similarity to rv3615/14c. The expression level of each gene in each strain is reported as the ratio between the expression level in M. tuberculosis
H37Ra culture 1, used as reference. For each strain, values were normalized to the level of 16S rRNA. Note that in M. tuberculosis a single rrs gene is
present. Primer and probe sequences of genes rv3614c, rv3865, rv3867, phoP, as well as of 16S rRNA are listed in Table S2.
doi:10.1371/journal.ppat.0040033.g006
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is not clear yet which factors might contribute to this effect.
However, upregulation of phoP and rv3614c-rv3616c was
observed after incubation of M. tuberculosis in 5mM H2O2
[37]. Furthermore, rv3614c-rv3616c were reported to be
transiently upregulated in the phagosome and under acidic
stress [38]. Altogether, from these reports it seems plausible
that the pleiotropic regulator PhoP is involved in the
regulation of rv3612c-rv3616c expression and thereby influ-
ences ESAT-6 secretion and virulence [16], but to unambig-
uously answer this question, virulence tests with recombinant
H37Ra and/or phoP ko strains that express rv3616c-3612c
under a constitutive promoter or a tetracycline inducable
expression system [39] will be needed. Construction of such
strains has recently been initiated as a first step of a future
study to gain deeper insight into signaling events and
regulation of the ESX-1 secretion system in different tubercle
bacilli, including members of the putative progenitor species
Mycobacterium prototuberculosis [40].
As in previous DNA/DNA microarray analyses [10], and
from inspection of the very recently released genome
sequence of H37Ra, no significant differences in the ESX-1
encoding region were found, the assumption that the
observed lack of ESAT-6 secretion in H37Ra may be caused
by factors outside of the RD1 region is very plausible.
In contrast, in another transcriptome analysis, Mostowy
and colleagues [11] found several genes of the RD1 region,
including that encoding ESAT-6, among the genes that were
at least 2.5-fold lower expressed in H37Ra than in H37Rv.
Our results obtained for ESAT-6 expression (Figure 5) and
the transcriptome data from Gao and colleagues [12] argue
against direct downregulation of ESAT-6 in H37Ra. However,
it is also possible that the observed differences may be caused
by variations of in vitro culture conditions.
In conclusion, in this work we report the identification and
profound consequences of the PhoP S219L mutation on the
widely used H37Ra strain. BLASTP comparisons of the PhoP
sequence showed that the predicted DNA binding region,
where the mutation occurred, is perfectly conserved among a
wide range of actinobacteria, with H37Ra being the only
strain showing such a mutation. By complementation with the
wild-type copy of PhoP, we obtained a significant increase in
virulence in ex vivo and animal models as well as restoration
of ESAT-6 secretion and the accompanying antigen-specific
immunological recognition by sensitized splenocytes or T cell
hybridomas.
It should be mentioned here that the SO2 phoP ko strain,
which showed strong ESAT-6 expression but little ESAT-6
secretion (Figure 5), induced only very reduced ESAT-6-
specific T cell responses (Figure 3). This strain was previously
used to vaccinate mice and guinea pigs and conferred good
protection against a challenge with virulent M. tuberculosis
[25]. As ESAT-6-specific T cell responses induced by this
strain are low, ESAT-6-based IFN-c production assays might
be used to differentiate between vaccination with SO2 and
infection with wild-type M. tuberculosis.
With its well documented role in virulence and strong T
cell antigenicity, ESAT-6 is one of the most important
proteins of M. tuberculosis involved in host pathogen inter-
action [5,41–43]. However, as previously observed in com-
plementation studies of BCG [18], the level of virulence
displayed by the phoP complemented H37Ra strain was still
substantially below that of wild-type H37Rv, arguing that the
strong attenuation of the H37Ra strain is likely based on
several different genetic lesions, such as the one responsible
for the absence of phthiocerol dimycocerosates (PDIM) [29],
that were probably introduced into this strain during years of
continued culture following the original event of attenuation
described by Steenken et al. in 1934 [6]. Indeed, preliminary
comparison of the 4.4-Mb genome of H37Rv [7]
(NC_000962) with the recently accessible H37Ra genome
(NC_009525) revealed 194 differences, including 126 SNPs,
16 deletions, 27 insertions, and 25 substitutions. At present,
we do not know how many of these differences actually
contribute to the attenuation of H37Ra, and it also remains
to be determined how many differences exist among the
various H37Ra strains that are presently used in the world-
wide tuberculosis research laboratories. The link described
here between mutation of phoP and consequences on ESAT-6
secretion, however, appears to be one factor that significantly
contributes to attenuation.
Finally, it is intriguing that both BCG and H37Ra, the two
most often used attenuated tubercle bacilli, are attenuated
for reasons linked to loss of ESAT-6 functions. Thus, our
results once more emphasize the great importance of the
ESX-1 system for tubercle bacilli and provide important new
information about the phoP-associated virulence regulation
in M. tuberculosis.
Materials and Methods
Bacterial strains and comparative genome sequencing. M. tuber-
culosis H37Ra corresponding to ATCC 25177 and M. tuberculosis
H37Rv were taken from stocks held at the Pasteur Institute. H37Ra
and H37Rv were grown in 400 ml of Dubos liquid medium (Difco)
supplemented with albumin-dextrose-catalase (ADC, Difco) at 37 8C
for 1 wk. Genomic DNA was made by standard methods [7].
Comparative mutational analysis of H37Ra and H37Rv was carried
out by NimbleGen Systems following a previously published method
using microarray-based sequencing arrays [13]. Verification of the
indicated SNPs was done by dye terminator cycle sequencing of PCR-
amplified H37Ra fragments following previously published methods
[44].
For construction of H37Ra fadE5, rpsL, and phoP knock-ins, high
concentrated plasmid DNA preparations from clones I230, I563, and
I36, selected from an ordered M. tuberculosis H37Rv library of
pYUB412 integrating shuttle cosmids [7,19], were individually
electroporated into H37Ra, following a previously published protocol
[45]. Transformants were selected on Middlebrook 7H11 medium
(Difco) supplemented with oleic acid-albumin-dextrose-catalase
(OADC, Difco) and 50 lg ml1 hygromycin. Resistant colonies
appearing after 4 wk were analyzed for the presence of the integrated
genes phoP, rpsL, or fadE5 by specific amplification and sequencing
(Figure S1). Proper integration of the cosmid was further determined
by Southern hybridization (Figure S2) following a previously
published method [4]. The previously described M. tuberculosis
MT103 phoP ko mutant SO2 [14,25], which carries an inactivated
phoP gene due to the insertion of a kanamycin cassette, was used for
control purposes in ESAT-6 expression and secretion assays.
Macrophage virulence assays. BMM were obtained as described
[24] by seeding bone marrow cells from 8-wk-old C57BL/6 mice in a
96-well plate at a density of 43 104 cells per well. Cells were cultured
in RPMI medium supplemented with 10% heat-inactivated fetal calf
serum, 10% L-cell-conditioned medium, and 2 mM L-glutamine.
Culture medium was changed at day 4 and then every 3 d, with cells
being differentiated into macrophages after 7 d. For the macrophage
virulence assay, cells were infected with bacterial suspensions of
H37Rv, H37Ra, and H37Ra knock-ins at a MOI of 1:1 and 10:1
(bacteria:cell). At 4 h, 1, 4, and 7 d after infection, macrophages were
lysed by addition of 0.1% Triton X-100 (Fluka) in PBS and the
number of intracellular bacteria was determined by plating serial
dilutions of cell lysates on Middlebrook 7H11 medium supplemented
with OADC.
Virulence studies in mice. Mycobacterial strains were grown and
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suspensions prepared as described previously [23]. 6-wk-old male C.B-
17/Icr Ico SCID mice (Charles River) were infected intravenously with
106 CFU. At 3 or 4 wk after infection mice were sacrificed and spleens
and lungs homogenized using an MM300 apparatus (Qiagen) and 2.5-
mm diameter glass beads. Serial 5-fold dilutions of organ homoge-
nates were plated on Middlebrook 7H11 agar supplemented with 50
lg of hygromycin or ampicilin / ml1 when appropriate, and the CFUs
were counted after 3–4 wk of incubation at 37 8C.
Splenocyte T cell response assays. For splenocyte T cell response
assays, adult C57BL/6 (H-2b) (Janvier) mice were injected subcuta-
neously with 106 CFU of H37Rv, H37Ra, or recombinant H37Ra
knock-in strains. 2 wk after immunization, splenocytes were cultured
(106 cells/well) with 10 lg/ml of purified protein derivatives (PPD)
(Statens Serum Institute), 4 lg/ml of recombinant ESAT-6, CFP-10
(kindly provided by Marcella Simsova and Peter Sebo), or MalE as
negative control, or with 10 lg/ml of synthetic peptides. After 72 h of
incubation, amounts of IFN-c were quantified in culture supernatants
using a sandwich ELISA (detection limit of 500 pg/ml) with AN-18 and
biotin-conjugated R4-6A2 monoclonal antibodies as described else-
where [23]. Results are expressed as the mean and standard deviation
of duplicate culture wells.
Generation of anti-ESAT-6 T cell hybridomas and detection of
ESAT-6:1–20 presentation upon infection of dendritic cells with
mycobacteria. T cell hybridomas specific for ESAT-6:1–20 peptide
were generated from C57BL/6 (H-2b) mice immunized s.c. with 50 lg/
mouse of the synthetic ESAT-6:1–20 peptide in Freund’s incomplete
adjuvant. 2 wk after immunization, total splenocytes were stimulated
with 10 lg/ml of ESAT-6:1–20 peptide. At day 4, viable cells were
harvested on Lympholyte M (Cedarlane Laboratories) and were fused
with an equal number of BW51–47 thymoma cells by use of
polyethylene glycol 1500 (Roche Diagnostics GmbH), as previously
described [46]. Hybridomas were screened for their capacity to
release IL-2 upon recognition of an immunodominant epitope
contained in the ESAT-6:1–20 peptide. Briefly, bone marrow–derived
dendritic cells (BM-DC) were stimulated overnight, in antibiotic-free
conditions, with ESAT-6:1–20 peptide (1 lg/ml), recombinant ESAT-6
(1 lg/ml), or an ESAT-6-expressing BCG::RD1 [18], at a MOI of 1:1.
BM-DC were then washed three times and co-cultured overnight with
T cell hybridomas. The presence of IL-2 in the supernatant of co-
cultures was monitored by standard IL-2-specific ELISA. L fibroblasts,
transfected with I-Ab or I-Ad molecules, were used as peptide
presenting cell, in the same type of assay for determination of the
H-2 restriction of the antigen presentation to these T cell hybrid-
omas. A selected T cell hybridoma (NB11), restricted by I-Ab, with the
detection limit of 6 nM of ESAT-6:1–20 peptide, was chosen to
determine the capacity of H37Ra, H37Ra knock-ins, and H37Rv to
induce presentation of ESAT-6:1–20 via the MHC-II pathway. An
anti-Ag85A:241–260 T cell hybridoma, (DE10) [46], was used in
parallel to detect the presentation of Ag85A:241–260 by I-Ab.
Preparation of cell lysates, supernatants, and western blotting.
Protein preparation of whole cell lysates and culture supernatants of
mycobacterial cultures was done as previously described [24]. Total
protein concentrations were determined by using a Bio-Rad protein
assay (Bio-Rad), and 15-lg samples were subjected to sodium dodecyl
sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) using NuPage
Bis-Tris Mini gels (Invitrogen) in NuPage MES running buffer
following the manufacturer’s recommendations. The immunoblot
analysis was carried out with mouse ESAT-6 monoclonal antibody
(Hyb 76–8; Antibody Shop, Statens Serum Institute) as described
previously [24], after proteins were transferred onto nitrocellulose
membranes using the iBlot Dry Blotting System (Invitrogen; Voltage
25V; Run time: 7 min).
Reverse transcription. To ensure the same amount of cDNA was
analysed in every specimen, reverse transcription was performed as a
separate step from PCR. The mRNA was then reverse transcribed into
cDNA (Reverse-iT Max 1st Strand Synthesis Kit, Abgene). Briefly, 1 lg
of RNA was added to a final reaction volume of 20 ll composed of 1
ll of random, 4 ll 10 3 RT Buffer, 2 ll dNTP mix, 1 ll QRTase
Enhancer, 1 ll reverse transcriptase and water. The reaction was
vortexed briefly and incubated at 42 8C for 1 h. The tubes were then
heated at 75 8C for 10 min to inactivate the reverse transcriptase. The
cDNA samples were then purified using Qiaquick Columns (Qiagen,
Incorporated) to remove unused dNTPs and any other DNA or RNA
material,25 bases in length. The cDNA was stored at20 8C prior to
analysis by real-time PCR.
Quantitative real-time PCR. Primers and probes used in qRT-PCR
are listed in Table S2. To perform qRT-PCR, 5 dilutions of M.
tuberculosis H37Rv cDNA were used as PCR templates for each
standard curve. Each standard dilution and each sample was tested in
duplicate and negative controls were included in each experiment.
Each amplification was performed in a 96-well PCR plate covered
with optical tape in the AB7300 real-time PCR instrument (Applied
Biosystems). A final volume of 20 ll was used containing 5 ng of cDNA
template, 10 ll of TaqMan Master Mix (Applied Biosystems), 1 ll Mix
containing Primers and Probes, and water. The reaction was
subjected to denaturation at 95 8C for 2 min followed by 40 cycles
of denaturation at 95 8C for 45 s, annealing/elongation at 60 8C for 1
min. Fluorescent data were specified for collection at the end of the
annealing/elongation step in each cycle.
For each gene, a standard curve of amplification was performed
using known amount of cDNA from H37Rv. Based on the CT values
obtained, a linear regression line was plotted using a custom made
software supplied with the AB7300 real-time PCR instrument and the
resulting equation is used to calculate the efficiency of amplification.
To normalize the results between samples, the 16S rRNA gene and the
H37Ra strain (culture number 1) were used as reference gene and
reference strain, respectively. The expression level of each gene was
reported as ratio of expression (fold induction) compared to the
expression level in H37Ra (culture 1), using following calculation:
ratio of induction ¼ Efficiency of amplification (gene of interest)DDCT,
where DCT¼CT(gene of interest)CT(16S rRNA) in each strain tested, and
DDCT ¼ DCT(strain tested)  DCT (H37Ra 1).
Supporting Information
Figure S1. Partial Sequences of Genes rpsL, fadE5, and phoP in M.
tuberculosis H37Ra and H37Ra Knock-In Strains
Arrows indicate the nucleotide variation at the corresponding SNP
site resulting from complementation with the wild-type gene from M.
tuberculosis H37Rv.
Found at doi:10.1371/journal.ppat.0040033.sg001 (212 KB PDF).
Figure S2. Restriction and Hybridization Profiles of M. tuberculosis
H37Ra and H37Ra::phoP
SpeI-digested, pulsed field gel electrophoresis (PFGE) profiles of M.
tuberculosis H37Ra and H37Ra::phoP (left panel), and after hybrid-
ization with a radiolabeled phoP probe (right panel).
Found at doi:10.1371/journal.ppat.0040033.sg002 (155 KB PDF).
Figure S3. Colony Morphology of Different M. tuberculosis H37 Strains
Found at doi:10.1371/journal.ppat.0040033.sg003 (35 KB PDF).
Figure S4. Sizes of Spleens from SCID Mice
SCID mice were intravenously infected with different M. tuberculosis
H37 strains (106 bacteria) for 3 wk (A) or 4 wk (B).
Found at doi:10.1371/journal.ppat.0040033.sg004 (59 KB PDF).
Table S1. Identity and Genomic Position of Mutations in the M.
tuberculosis H37Ra Strain Used in This Study
Found at doi:10.1371/journal.ppat.0040033.st001 (48 KB DOC).
Table S2. Primers and Probes Used for Quantitative RT-PCR
Found at doi:10.1371/journal.ppat.0040033.st002 (22 KB DOC).
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